{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:45:49Z","timestamp":1778507149542,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11605-021-04953-y","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T14:05:07Z","timestamp":1614261907000},"page":"2908-2919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative"],"prefix":"10.1016","volume":"25","author":[{"given":"Nadege","family":"Fackche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan K.","family":"Schmocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boateng","family":"Kubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Leiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Powers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jula","family":"Veerapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callisia","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Clark","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikrom","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Pokrzywa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Lafaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byrne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Y.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-9710","authenticated-orcid":false,"given":"Jonathan B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/COC.0000000000000210","article-title":"Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis","volume":"40","author":"Shaib","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1007\/s11605-021-04953-y_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00308632","article-title":"Patient Selection and Treatment of Peritoneal Carcinomatosis from Colorectal and Appendiceal Cancer","volume":"19","author":"Sugarbaker","year":"1995","journal-title":"World J. Surg."},{"issue":"4","key":"10.1007\/s11605-021-04953-y_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal Carcinomatosis from Digestive Tract Cancer: New Management by Cytoreductive Surgery and Intraperitoneal Chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1007\/s11605-021-04953-y_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bjs5.97","article-title":"Recurrence of Pseudomyxoma Peritonei after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"3","author":"Mercier","year":"2018","journal-title":"BJS Open"},{"issue":"7","key":"10.1007\/s11605-021-04953-y_bb0030","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1245\/s10434-019-07374-z","article-title":"Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional\/Poor Survival After CRS\/HIPEC","volume":"26","author":"Munoz-Zuluaga","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0035","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/bjs.10716","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendicular and Extra-Appendicular Origin","volume":"105","author":"Delhorme","year":"2018","journal-title":"BJS"},{"issue":"1","key":"10.1007\/s11605-021-04953-y_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00423-014-1253-z","article-title":"Morbidity, Mortality, and Oncological Outcomes of 401 Consecutive Cytoreductive Procedures with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"400","author":"Desantis","year":"2015","journal-title":"Langenbecks Arch. Surg."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still Be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1007\/s11605-021-04953-y_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma Peritonei: A French Multicentric Study of 301 Patients Treated with Cytoreductive Surgery and Intraperitoneal Chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur. J. Surg. Oncol. EJSO"},{"issue":"4_suppl","key":"10.1007\/s11605-021-04953-y_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/jco.2012.30.4_suppl.532","article-title":"Early and Long-Term Outcome Data on 2,298 Patients with Pseudomyxoma Peritonei of Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J. Clin. Oncol"},{"issue":"4","key":"10.1007\/s11605-021-04953-y_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 Tumor Markers in Diagnosis and Prognostic Assessment of Mucinous Epithelial Cancers of the Appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"10.1007\/s11605-021-04953-y_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","article-title":"Expression of CEA, CA19-9, CA125, and EpCAM in Pseudomyxoma Peritonei","volume":"54","author":"Nummela","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1007\/s11605-021-04953-y_bb0070","doi-asserted-by":"crossref","unstructured":"Tsai, S.; George, B.; Wittmann, D.; Ritch, P. S.; Krepline, A. N.; Aldakkak, M.; Barnes, C. A.; Christians, K. K.; Dua, K.; Griffin, M.; Hagen, C.; Hall, W. A.; Erickson, B. A.; Evans, D. B. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Ann. Surg.2018. https:\/\/doi.org\/10.1097\/SLA.0000000000003049.","DOI":"10.1097\/SLA.0000000000003049"},{"issue":"4","key":"10.1007\/s11605-021-04953-y_bb0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1272\/jnms.84.170","article-title":"Serum CA 125 Level after Neoadjuvant Chemotherapy Is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer. J. Nippon Med. Sch","volume":"84","author":"Matsuhashi","year":"2017","journal-title":"Nippon Ika Daigaku Zasshi"},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0080","first-page":"3157","article-title":"Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer","volume":"37","author":"Muallem","year":"2017","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0085","first-page":"231","article-title":"Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers","volume":"56","author":"Capocasale","year":"1985","journal-title":"Acta Bio-Medica Ateneo Parm. Organo Della Soc. Med. E Sci. Nat. Parma"},{"issue":"66","key":"10.1007\/s11605-021-04953-y_bb0090","first-page":"476","article-title":"Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients","volume":"11","author":"Grotowski","year":"2001","journal-title":"Pol. Merkur. Lek. Organ Pol. Tow. Lek."},{"issue":"33","key":"10.1007\/s11605-021-04953-y_bb0095","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO. ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"10.1007\/s11605-021-04953-y_bb0100","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.7314\/APJCP.2013.14.7.4289","article-title":"CEA and CA 19-9 Are Still Valuable Markers for the Prognosis of Colorectal and Gastric Cancer Patients","volume":"14","author":"Sisik","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1007\/s11605-021-04953-y_bb0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","article-title":"Significance of Serum Tumor Marker Levels in Peritoneal Carcinomatosis of Appendiceal Origin","volume":"20","author":"Wagner","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1007\/s11605-021-04953-y_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0115","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00268-013-1988-7","article-title":"Preoperative Carcinoembryonic Antigen Level Predicts Prognosis in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"37","author":"Canbay","year":"2013","journal-title":"World J. Surg."},{"issue":"8","key":"10.1007\/s11605-021-04953-y_bb0120","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","article-title":"Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1007\/s11605-021-04953-y_bb0125","unstructured":"Arabzadeh, N. B. and A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis | Kopernio https:\/\/kopernio.com\/viewer?doi=10.1007%2Fs10555-013-9444-6&token=WzE5MjEwNjAsIjEwLjEwMDcvczEwNTU1LTAxMy05NDQ0LTYiXQ.HU1NehJzui5sfGkVp1UyzCvpKEM."},{"key":"10.1007\/s11605-021-04953-y_bb0130","unstructured":"al, N. S. and G. M. et. Carcinoembryonic Antigen (CEA) Inhibits NK Killing via Interaction with CEA-Related Cell Adhesion Molecule 1 | Kopernio https:\/\/kopernio.com\/viewer?doi=10.4049%2Fjimmunol.174.11.6692&token=WzE5MjEwNjAsIjEwLjQwNDkvamltbXVub2wuMTc0LjExLjY2OTIiXQ.E-Otoz3WnKtEnxJElZpL4u32hJ4 (accessed May 3, 2020)."},{"issue":"3","key":"10.1007\/s11605-021-04953-y_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4174\/astr.2019.96.3.107","article-title":"High Preoperative Serum CA 19-9 Levels Can Predict Poor Oncologic Outcomes in Colorectal Cancer Patients on Propensity Score Analysis","volume":"96","author":"Shin","year":"2019","journal-title":"Ann. Surg. Treat. Res."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0140","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1007\/s11605-021-04953-y_bb0145","unstructured":"al, M. J. C. and K. J. L. et. Preoperative Serum CA 19-9 Level as a Predictive Factor for Recurrence after Curative Resection in Biliary Tract Cancer | Kopernio https:\/\/kopernio.com\/viewer?doi=10.1245%2Fs10434-010-1529-7&token=WzE5MjEwNjAsIjEwLjEyNDUvczEwNDM0LTAxMC0xNTI5LTciXQ.jNtpMC9liN5QDD_WBu8mT3PgLLQ (accessed May 3, 2020)."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jso.21679","article-title":"Neoadjuvant FOLFOX Chemotherapy in 34 Consecutive Patients with Mucinous Peritoneal Carcinomatosis of Appendiceal Origin","volume":"102","author":"Sugarbaker","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"18_suppl","key":"10.1007\/s11605-021-04953-y_bb0155","doi-asserted-by":"crossref","first-page":"15115","DOI":"10.1200\/jco.2007.25.18_suppl.15115","article-title":"Is There a Role for Neoadjuvant Chemotherapy in the Management of Non-Carcinoid Epithelial Neoplasms of the Appendix?","volume":"25","author":"Katz","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1007\/s11605-021-04953-y_bb0160","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-012-2789-1","article-title":"Assessment of Neoadjuvant Chemotherapy on Operative Parameters and Outcome in Patients with Peritoneal Dissemination from High-Grade Appendiceal Cancer","volume":"20","author":"Turner","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1007\/s11605-021-04953-y_bb0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00000658-198012000-00010","article-title":"The Use of Preoperative Plasma CEA Levels for the Stratification of Patients After Curative Resection of Colorectal Cancers","volume":"192","author":"Goslin","year":"1980","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1007\/s11605-021-04953-y_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00163573","article-title":"Metastatic Potential of Human Colon Cancer Cell Lines: Relationship to Cellular Differentiation and Carcinoembryonic Antigen Production","volume":"10","author":"Wagner","year":"1992","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1007\/s11605-021-04953-y_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The Carcinoembryonic Antigen (CEA) Family: Structures, Suggested Functions and Expression in Normal and Malignant Tissues","volume":"9","author":"Hammarstr\u00f6m","year":"1999","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1007\/s11605-021-04953-y_bb0180","first-page":"173","article-title":"Carbohydrate Antigen 19-9 (CA 19-9) Is an Independent Prognostic Indicator in Pseudomyxoma Peritonei Post Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy","volume":"4","author":"Koh","year":"2013","journal-title":"J. Gastrointest. Oncol."},{"issue":"12","key":"10.1007\/s11605-021-04953-y_bb0185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ejso.2017.09.009","article-title":"CA 19-9 to Peritoneal Carcinomatosis Index (PCI) Ratio Is Prognostic in Patients with Epithelial Appendiceal Mucinous Neoplasms and Peritoneal Dissemination Undergoing Cytoreduction Surgery and Intraperitoneal Chemotherapy: A Retrospective Cohort Study","volume":"43","author":"Kozman","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"10.1007\/s11605-021-04953-y_bb0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated Peritoneal Adenomucinosis and Peritoneal Mucinous Carcinomatosis. A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to \u201cPseudomyxoma Peritonei.\u201d","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1007\/s11605-021-04953-y_bb0195","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdr561","article-title":"The Prognostic and Predictive Value of Serum CA19.9 in Pancreatic Cancer","volume":"23","author":"Humphris","year":"2012","journal-title":"Ann. Oncol."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-04953-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-021-04953-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23008338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23008338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-04953-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:00:41Z","timestamp":1761076841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23008338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1091255X23008338"],"URL":"https:\/\/doi.org\/10.1007\/s11605-021-04953-y","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-021-04953-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}